» Articles » PMID: 29929534

Integration of Conventional Cell Viability Assays for Reliable and Reproducible Read-outs: Experimental Evidence

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2018 Jun 23
PMID 29929534
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Short-term viability assays of cultured cells in 96-well plates are routinely used to determine the cytotoxicity or safety of drugs. These are often based on the formation of chromogen, generated selectively in viable cells. The innate problems of such short-term cell viability assays include (i) effect of drugs is determined by cell density (ii) some drugs have slow/gradual effect and hence may escape such assays, (iii) cell morphology that reveal significant hints to molecular signaling underlining the effect of drugs cannot be effectively captured, (iv) long-term effect on viability and clonogenic potential of cells cannot be determined and (v) herbal extracts often possess intrinsic color that interferes with spectrophotometer estimation. In light of the ease and importance of cell culture-based assessment of drug safety and cytotoxicity, we attempted to combine the conventional cell-based assays in a way that allows multiple readouts (quantitative and qualitative) from a single experiment, and avoids the drawbacks of color interference.

Results: We have established and validated (using 16 types of cultured mammalian cells) a Quantitative and Qualitative Cell Viability assay in 12-well cell culture plates. It overcomes several shortcomings as discussed above and allows long-term observations on cell morphology and clonogenicity.

Citing Articles

Sustainable Primary Cell Banking for Topical Compound Cytotoxicity Assays: Protocol Validation on Novel Biocides and Antifungals for Optimized Burn Wound Care.

Liao Z, Laurent N, Hirt-Burri N, Scaletta C, Abdel-Sayed P, Raffoul W Eur Burn J. 2024; 5(3):249-270.

PMID: 39599948 PMC: 11544888. DOI: 10.3390/ebj5030024.


Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens.

Lyles R, Martinez M, Sherman B, Schurer S, Burnstein K PLoS One. 2023; 18(10):e0287126.

PMID: 37815978 PMC: 10564233. DOI: 10.1371/journal.pone.0287126.


Bioactivity Guided Study for the Isolation and Identification of Antidiabetic Compounds from Edible Seaweed-.

Unnikrishnan P, Animish A, Madhumitha G, Suthindhiran K, Jayasri M Molecules. 2022; 27(24).

PMID: 36557959 PMC: 9783910. DOI: 10.3390/molecules27248827.


Evaluation of Cytotoxic Potential of Extracts on Human Hepatocarcinoma HepG2 and Normal HEK293T Cell Lines.

Kalsoom A, Altaf A, Ashraf M, Ali M, Aftab S, Sattar H Biomed Res Int. 2022; 2022:1279961.

PMID: 36193312 PMC: 9526597. DOI: 10.1155/2022/1279961.


Modeling chemotherapy induced peripheral neuropathy (CIPN) in vitro: Prospects and limitations.

Lehmann H, Staff N, Hoke A Exp Neurol. 2019; 326:113140.

PMID: 31812556 PMC: 8926153. DOI: 10.1016/j.expneurol.2019.113140.


References
1.
Eckhouse S, Lewison G, Sullivan R . Trends in the global funding and activity of cancer research. Mol Oncol. 2009; 2(1):20-32. PMC: 5527789. DOI: 10.1016/j.molonc.2008.03.007. View

2.
Jelliffe R, Schumitzky A, Bayard D, Fu X, Neely M . Describing Assay Precision-Reciprocal of Variance Is Correct, Not CV Percent: Its Use Should Significantly Improve Laboratory Performance. Ther Drug Monit. 2015; 37(3):389-94. PMC: 4435937. DOI: 10.1097/FTD.0000000000000168. View

3.
van Tonder A, Joubert A, Cromarty A . Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays. BMC Res Notes. 2015; 8:47. PMC: 4349615. DOI: 10.1186/s13104-015-1000-8. View

4.
Hanahan D, Weinberg R . The hallmarks of cancer. Cell. 2000; 100(1):57-70. DOI: 10.1016/s0092-8674(00)81683-9. View

5.
Patafio F, Brooks S, Wei X, Peng Y, Biagi J, Booth C . Research output and the public health burden of cancer: is there any relationship?. Curr Oncol. 2016; 23(2):75-80. PMC: 4835015. DOI: 10.3747/co.23.2935. View